IHC Any Single Marker (HER2NEU/C4D/EBER/Ki67)
Introduction to the Test
The IHC Any Single Marker (HER2NEU/C4D/EBER/Ki67) test is a crucial diagnostic procedure used in oncology to evaluate specific protein expressions in tissue samples. This test plays a significant role in the diagnosis and treatment planning of various cancers by providing insights into tumor biology. Understanding the expression of these markers can help oncologists tailor treatment strategies that are most effective for individual patients.
What the Test Measures
This immunohistochemical (IHC) test detects the presence of specific proteins, namely HER2/neu, C4D, EBER, and Ki67, in the tissue samples. Each of these markers has distinct implications for cancer prognosis and treatment:
- HER2/neu: Indicates aggressive tumor behavior and guides the use of targeted therapies.
- C4D: Helps in understanding the tumor microenvironment.
- EBER: Associated with certain types of lymphomas.
- Ki67: A marker for cell proliferation, indicating how quickly a tumor is growing.
Who Should Consider This Test?
This test is recommended for patients who exhibit symptoms or have risk factors associated with cancers, particularly breast cancer and lymphomas. Patients with a family history of cancer, those experiencing unexplained weight loss, or abnormal imaging results may also benefit from this test.
Benefits of Taking the Test
Understanding the results of the IHC Any Single Marker test can provide several advantages:
- Guides treatment decisions, including the use of targeted therapies.
- Helps predict patient prognosis.
- Facilitates personalized medicine approaches.
- Improves communication between healthcare providers and patients regarding treatment plans.
Understanding Your Results
Results from the IHC Any Single Marker test will be interpreted by a qualified pathologist. They will assess the expression levels of the markers and provide a comprehensive report that can assist your oncologist in making informed treatment decisions. It is essential to discuss your results with your healthcare provider to understand their implications fully.
Test Pricing
| Price Type | Amount (NGN) |
|---|---|
| Discount Price | 90,000 NGN |
| Regular Price | 120,000 NGN |
Booking the Test
To book the IHC Any Single Marker (HER2NEU/C4D/EBER/Ki67) test, please ensure you have a doctor’s prescription. Note that this test is not applicable for patients undergoing surgery, pregnant women, or those planning to travel abroad. For more information or to schedule your test, please call or WhatsApp us at +2348110567037.
Take the first step towards understanding your health today!
